NO991405D0 - Belagt partikkelformulering - Google Patents
Belagt partikkelformuleringInfo
- Publication number
- NO991405D0 NO991405D0 NO991405A NO991405A NO991405D0 NO 991405 D0 NO991405 D0 NO 991405D0 NO 991405 A NO991405 A NO 991405A NO 991405 A NO991405 A NO 991405A NO 991405 D0 NO991405 D0 NO 991405D0
- Authority
- NO
- Norway
- Prior art keywords
- coated particle
- particle formulation
- formulation
- coated
- particle
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2663396P | 1996-09-24 | 1996-09-24 | |
PCT/US1997/016547 WO1998013027A1 (en) | 1996-09-24 | 1997-09-18 | Coated particle formulation |
Publications (2)
Publication Number | Publication Date |
---|---|
NO991405L NO991405L (no) | 1999-03-23 |
NO991405D0 true NO991405D0 (no) | 1999-03-23 |
Family
ID=21832952
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO991405A NO991405D0 (no) | 1996-09-24 | 1999-03-23 | Belagt partikkelformulering |
Country Status (21)
Country | Link |
---|---|
US (1) | US20010020032A1 (no) |
EP (1) | EP0830858A1 (no) |
JP (1) | JP2001501207A (no) |
KR (1) | KR20000048540A (no) |
CN (1) | CN1230883A (no) |
AR (1) | AR009802A1 (no) |
AU (1) | AU719788B2 (no) |
BR (1) | BR9713215A (no) |
CA (1) | CA2266448A1 (no) |
CO (1) | CO4910139A1 (no) |
CZ (1) | CZ98899A3 (no) |
EA (1) | EA001610B1 (no) |
HU (1) | HUP9904065A3 (no) |
ID (1) | ID21762A (no) |
IL (1) | IL128845A0 (no) |
NO (1) | NO991405D0 (no) |
PE (1) | PE27899A1 (no) |
PL (1) | PL332503A1 (no) |
TR (1) | TR199900651T2 (no) |
WO (1) | WO1998013027A1 (no) |
ZA (1) | ZA978517B (no) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9922271D0 (en) * | 1999-09-21 | 1999-11-17 | Zeneca Ltd | Formulation |
TWI275394B (en) * | 2000-01-26 | 2007-03-11 | Asahi Chemical Corp | Mizoribin tablet improved with color tone change |
US6740753B2 (en) | 2001-01-04 | 2004-05-25 | Geneva Pharmaceuticals, Inc. | Olanzapine crystal modification |
DE10232113A1 (de) * | 2002-07-16 | 2004-01-29 | Bayer Ag | Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel |
SI21303A (sl) * | 2002-10-18 | 2004-04-30 | Krka, Tovarna Zdravil, D.D.,, Novo Mesto | Farmacevtska formulacija olanzapina |
CA2510320C (en) | 2002-12-20 | 2012-10-09 | St. James Associates Llc/Faber Research Series | Coated particles for sustained-release pharmaceutical administration |
SI21402A (sl) | 2003-02-12 | 2004-08-31 | LEK farmacevtska dru�ba d.d. | Obloženi delci in farmacevtske oblike |
JP4808612B2 (ja) * | 2003-04-25 | 2011-11-02 | 田辺三菱製薬株式会社 | アルキレンジオキシベンゼン誘導体を含む経口投与用組成物 |
WO2005009407A2 (en) * | 2003-07-29 | 2005-02-03 | Ranbaxy Laboratories Limited | Oral pharmaceutical formulations of olanzapine |
WO2006027800A1 (en) * | 2004-09-06 | 2006-03-16 | Shasun Chemicals And Drugs Limited | A novel process for preparation of a pharmaceutically pure polymorphic form 1 of olanzapine |
CZ200563A3 (cs) * | 2005-02-02 | 2006-10-11 | Zentiva, A. S. | Lécivý prípravek obsahující jako úcinnou slozku olanzapin a zpusob jeho výroby |
WO2007049304A2 (en) * | 2005-10-27 | 2007-05-03 | Jubilant Organosys Limited | Stable coated pharmaceutical formulation of olanzapine and process for preparing the same |
ES2279715B1 (es) * | 2005-12-26 | 2008-06-01 | Laboratorios Lesvi, S.L. | Formulacion oral de olanzapina. |
WO2007134845A2 (en) * | 2006-05-18 | 2007-11-29 | Synthon B.V. | Olanzapine pharmaceutical composition |
EP2043612B1 (en) * | 2006-07-05 | 2010-04-28 | Bilim Ilac Sanayii Ve Ticaret A.S. | A stable olanzapine formulation with antioxidants |
US20080138409A1 (en) * | 2006-09-29 | 2008-06-12 | Osinga Niels J | Olanzapine pharmaceutical composition |
ES2533075T3 (es) * | 2010-04-30 | 2015-04-07 | Bristol-Myers Squibb Company | Composiciones farmacéuticas que comprenden N-(4-(2-amino-3-cloropiridin-4-iloxi)-3-fluorofenil)-4-etoxi-1-(4-fluorofenil)-2-oxo-1,2-dihidropiridin-3-carboxamida |
WO2012153347A2 (en) | 2011-05-04 | 2012-11-15 | Zentiva K.S. | Oral pharmaceutical composition of olanzapine form 1 |
US9987233B2 (en) | 2013-03-21 | 2018-06-05 | Eupraxia Pharmaceuticals USA LLC | Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith |
EP3206672B1 (en) | 2015-10-27 | 2018-03-14 | Eupraxia Pharmaceuticals Inc. | Sustained release formulations of local anesthetics |
CN107007559B (zh) * | 2017-04-21 | 2020-05-15 | 浙江京新药业股份有限公司 | 一种稳定的口服药物组合物及其制备方法 |
MX2020005517A (es) | 2017-12-05 | 2020-11-09 | Sunovion Pharmaceuticals Inc | Formas cristalinas y metodos de produccion de las mismas. |
US10369134B2 (en) | 2017-12-05 | 2019-08-06 | Sunovion Pharmaceuticals Inc. | Nonracemic mixtures and uses thereof |
KR20220018004A (ko) | 2019-06-04 | 2022-02-14 | 선오비온 파마슈티컬스 인코포레이티드 | 조절 방출 제형 및 이의 용도 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4820522A (en) * | 1987-07-27 | 1989-04-11 | Mcneilab, Inc. | Oral sustained release acetaminophen formulation and process |
US5605897A (en) * | 1991-04-23 | 1997-02-25 | Eli Lilly And Company | 2-methyl-thieno-benzodiazepine |
ZA922777B (en) * | 1991-04-29 | 1993-10-15 | Lilly Co Eli | Pharmaceutical formulation containing dirithromycin |
JPH05194225A (ja) * | 1991-11-07 | 1993-08-03 | Yoshitomi Pharmaceut Ind Ltd | 安定化された抗潰瘍剤含有製剤 |
AU668159B2 (en) * | 1992-05-29 | 1996-04-26 | Lilly Industries Limited | Pharmaceutical compounds |
SE9302395D0 (sv) * | 1993-07-09 | 1993-07-09 | Ab Astra | New pharmaceutical formulation |
CR5278A (es) * | 1995-03-24 | 1996-07-04 | Lilly Co Eli | Formulacion oral de 2-metil-tieno-benzodiacepina |
US5637584A (en) * | 1995-03-24 | 1997-06-10 | Eli Lilly And Company | Solvate of olanzapine |
EP0733368A1 (en) * | 1995-03-24 | 1996-09-25 | Eli Lilly And Company | Granule fomulation for olanzapine |
-
1997
- 1997-09-18 JP JP10515724A patent/JP2001501207A/ja not_active Ceased
- 1997-09-18 AU AU44230/97A patent/AU719788B2/en not_active Ceased
- 1997-09-18 TR TR1999/00651T patent/TR199900651T2/xx unknown
- 1997-09-18 ID IDW990060A patent/ID21762A/id unknown
- 1997-09-18 BR BR9713215-2A patent/BR9713215A/pt not_active IP Right Cessation
- 1997-09-18 PL PL97332503A patent/PL332503A1/xx unknown
- 1997-09-18 CA CA002266448A patent/CA2266448A1/en not_active Abandoned
- 1997-09-18 HU HU9904065A patent/HUP9904065A3/hu unknown
- 1997-09-18 WO PCT/US1997/016547 patent/WO1998013027A1/en not_active Application Discontinuation
- 1997-09-18 CN CN97198099A patent/CN1230883A/zh active Pending
- 1997-09-18 EA EA199900331A patent/EA001610B1/ru not_active IP Right Cessation
- 1997-09-18 IL IL12884597A patent/IL128845A0/xx unknown
- 1997-09-18 CZ CZ99988A patent/CZ98899A3/cs unknown
- 1997-09-18 KR KR1019990702455A patent/KR20000048540A/ko not_active Application Discontinuation
- 1997-09-22 EP EP97307380A patent/EP0830858A1/en not_active Withdrawn
- 1997-09-22 CO CO97055063A patent/CO4910139A1/es unknown
- 1997-09-22 ZA ZA978517A patent/ZA978517B/xx unknown
- 1997-09-23 US US08/935,882 patent/US20010020032A1/en not_active Abandoned
- 1997-09-23 PE PE1997000854A patent/PE27899A1/es not_active Application Discontinuation
- 1997-09-23 AR ARP970104363A patent/AR009802A1/es unknown
-
1999
- 1999-03-23 NO NO991405A patent/NO991405D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HUP9904065A2 (hu) | 2000-04-28 |
BR9713215A (pt) | 2000-04-04 |
AU719788B2 (en) | 2000-05-18 |
PL332503A1 (en) | 1999-09-13 |
HUP9904065A3 (en) | 2001-10-29 |
EA001610B1 (ru) | 2001-06-25 |
PE27899A1 (es) | 1999-03-12 |
IL128845A0 (en) | 2000-01-31 |
KR20000048540A (ko) | 2000-07-25 |
EP0830858A1 (en) | 1998-03-25 |
NO991405L (no) | 1999-03-23 |
CN1230883A (zh) | 1999-10-06 |
US20010020032A1 (en) | 2001-09-06 |
ZA978517B (en) | 1999-03-23 |
AR009802A1 (es) | 2000-05-03 |
ID21762A (id) | 1999-07-22 |
TR199900651T2 (xx) | 1999-07-21 |
CZ98899A3 (cs) | 1999-12-15 |
EA199900331A1 (ru) | 2000-04-24 |
JP2001501207A (ja) | 2001-01-30 |
CA2266448A1 (en) | 1998-04-02 |
AU4423097A (en) | 1998-04-17 |
CO4910139A1 (es) | 2000-04-24 |
WO1998013027A1 (en) | 1998-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO991405D0 (no) | Belagt partikkelformulering | |
DE69705347D1 (de) | Überzugsmittel | |
DE69723347D1 (de) | Beschichtete SiO2-Teilchen | |
DE69817865D1 (de) | Pulverbeschichtungsanlage | |
DE69725265D1 (de) | Pulverlack | |
DE69501075D1 (de) | Überzugszusammensetzung | |
FI955588A (fi) | Päällystyskoostumus | |
ID26820A (id) | Aglomerat partikel | |
DE69509440T2 (de) | Pulverlack | |
DE69717521T2 (de) | Pulverlack | |
DE59810370D1 (de) | Pulverlack | |
DK0941290T3 (da) | Coatingsammensætninger | |
DE69510593T2 (de) | Pulverbeschichtung | |
DE69718757D1 (de) | Pulverlackzusammensetzung | |
DE59506722D1 (de) | Pulverbeschichtigungsanlage | |
DE69715718D1 (de) | Beschichtungszusammensetzung | |
DE59509148D1 (de) | Puderbestäubungsgerät | |
DE59610452D1 (de) | Pulverlack | |
DE69502713T2 (de) | Witterungsbeständige pulverbeschichtigungsmasse | |
DE19581452T1 (de) | Beschichtungszusammensetzung | |
ATE411425T1 (de) | Beschichtungsmittel | |
DE59701322D1 (de) | Flüssigkeitsdurchlässiger belag | |
DE59606302D1 (de) | Pulverlack | |
NO985740D0 (no) | Vµskegjennomtrengelig belegg | |
DK0942053T3 (da) | Coatingmateriale |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |